mr 2034 has been researched along with enkephalin, d-penicillamine (2,5)- in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (enkephalin, d-penicillamine (2,5)-) | Trials (enkephalin, d-penicillamine (2,5)-) | Recent Studies (post-2010) (enkephalin, d-penicillamine (2,5)-) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 1,314 | 0 | 73 |
| Protein | Taxonomy | mr 2034 (IC50) | enkephalin, d-penicillamine (2,5)- (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0016 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, CB | 1 |
1 other study(ies) available for mr 2034 and enkephalin, d-penicillamine (2,5)-
| Article | Year |
|---|---|
New approaches to the evaluation of opioid agonists and antagonists upon the isolated, electrically stimulated mouse vas deferens preparation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzodiazepines; Benzomorphans; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Oligopeptides; Pyrrolidines; Receptors, Opioid; Vas Deferens | 1987 |